METHOD OF INHIBITING TREM-1
Application
US20260076966A1
Kind: A1
Mar 19, 2026
Assignee
University of Florida Research Foundation, Incorporated
Inventors
Patrick R. Griffin, Mi Ra Chang, Jason Fisherman, Peter Suzman
Abstract
Disclosed herein are methods and uses of the polypharmacological modulator SR1903 and related compounds for inhibiting triggering receptor expressed on myeloid cells-1 (TREM-1) and treating diseases and conditions that are related to or mediated by TREM-1, such as inflammatory diseases, autoimmune diseases, metabolic disorders, and castration resistant prostate cancer (CRPC).
CPC Classifications
A61K 31/506
A61P 3/04
A61P 29/00
Filing Date
2025-06-25
Application No.
19249268